myPEPTSemax
Semax peptide (MEHFPGP) — synthetic heptapeptide analogue of the ACTH(4–7) fragment, studied in neuropeptide and neuroprotection research.
Tap I use this — we'll set up your dose, reminders & journey in 30 seconds.
Semax is a synthetic heptapeptide analogue of the ACTH(4–7) fragment of adrenocorticotropic hormone, first developed at the Institute of Molecular Genetics in Moscow. Investigations have centred on its apparent neurotrophin-like behaviour — in particular its reported interaction with BDNF and TrkB receptor signalling, pathways studied in the context of neuronal survival and synaptic plasticity — as well as its influence on dopaminergic and serotonergic neurotransmission and on hypothalamic-pituitary-adrenal axis responses in pre-clinical models. Its ACTH-derived structure, paired with the absence of adrenocorticotropic activity, makes it a reference tool for laboratories studying neuropeptide pharmacology, cerebrovascular biology, and central-nervous-system peptide signalling. Supplied at ≥99% verified purity with a batch Certificate of Analysis from independent lab testing, lyophilized and shipped in research-grade packaging. Strictly for laboratory research use only.
- Peptide
- Semax
- Strength
- 5 mg
- Package
- 5 mg
- Purity
- ≥99%
- Form
- vial
